News

Hims & Hers stock is on the upswing after the company secured a weight-loss drug partnership. Hims & Hers is acquiring its ...
Texas reports no new measles cases for the first time since February, maintaining 742 total cases. Meanwhile, Novo Nordisk's Ozempic is linked to rare serious eye disorders, possibly causing vision ...
Eli Lilly & Co. increased sales of the weight-loss and diabetes drug Mounjaro 60% in India in May from April in its second ...
The presence of multinational pharma companies (MNCs) in India's drug market continues to shrink, reaching 14.5% in May 2025 ...
Eli Lilly's weight-loss and diabetes drug Mounjaro, has seen sales in India jump 60 per cent between April and May. The ...
Wall Street gains as S&P 500 surpasses 6,000; key healthcare stock movers revealed. Explore top deals, trends, and regulatory updates in the sector.
Eli Lilly's weight-loss and diabetes drug, Mounjaro, has experienced a 60% sales increase in India between April and May.
The jobless rate held steady in May, but forecasts signal labor market weakness ahead, with inflation limiting Fed action.
Experts suggest that weight-loss jabs may require long-term use to achieve lasting benefits for both patients and the NHS.
Bank of America Corp DE lowered its stake in shares of BNY Mellon International Equity ETF (NYSEARCA:BKIE – Free Report) by 5.9% during the fourth quarter, HoldingsChannel reports. The firm owned ...
Bank of America Corp DE reduced its position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN – Free Report) by 4.4% in the 4th quarter, according to its most recent Form 13F filing with the ...
After a simulation recently showed what happens to your body once you inject the drug, some were left horrified, but now a ...